Day: March 21, 2022
Why Wealth Managers Are the Ultimate Private Market Matchmakers
‘Why Wealth Managers Are the Ultimate Private Market Matchmakers’ published by Hywin Wealth, VP Bank and WealthBriefingAsia on March, 2022SHANGHAI, China, March 21, 2022 (GLOBE NEWSWIRE) — Demand for private market opportunities is strong among investors in the Asia Pacific region, according to a new industry report jointly issued by Hywin Holdings Ltd. (“Hywin Wealth”, “Hywin”, or the “Company”) (NASDAQ: HYW), a leading independent wealth management service provider in China, with Liechtenstein-based VP Bank Ltd. and WealthBriefingAsia.
Over three quarters, or 77% of wealth management professionals, perceive current APAC investor demand for private market investment opportunities as strong, while 16 percent say demand is very strong, according...
Zai Lab Presents Positive Results from Phase 3 PRIME Study of ZEJULA® (Niraparib) at Society of Gynecologic Oncology Meeting
Written by Customer Service on . Posted in Public Companies.
PRIME study demonstrates that niraparib treatment had a statistically significant and clinically meaningful improvement in progression-free survival in the overall study population regardless of biomarker status when compared to placeboThe primary endpoint of the trial was met, with median progression-free survival of 24.8 months for niraparib patients versus 8.3 months for patients taking placeboTreatment was tolerable in the population studied and showed a safety profile consistent with previous trialsSHANGHAI and SAN FRANCISCO and CAMBRIDGE, Mass., March 20, 2022 (GLOBE NEWSWIRE) — Zai Lab Limited (NASDAQ: ZLAB; HKEX: 9688), a patient-focused, innovative, commercial-stage, global biopharmaceutical company, today presented data from the Phase 3 PRIME study of ZEJULA (niraparib) as maintenance therapy at the Society of...